Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
!!Link opens in a new tab
!!Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
The treatment of cognitive dysfunction in schizophrenia
Sophia Frangou
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The treatment of cognitive dysfunction in schizophrenia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Schizophrenia
100%
Cognitive Dysfunction
100%
Antipsychotics
33%
Cognitive Function
16%
Therapeutic Target
16%
Cholinergic System
16%
Psychosocial Outcomes
16%
Executive Function
16%
Cognitive Deficits
16%
Motor Control
16%
Poor Clinical Outcomes
16%
Stable Patients
16%
Serotonergic System
16%
Dopaminergic System
16%
General Intellectual Ability
16%
Glutamatergic System
16%
Noradrenergic System
16%
Treatment Recommendations
16%
Cognitive Rehabilitation
16%
Specific Treatment
16%
Rehabilitation Protocol
16%
Remedial Treatment
16%
Controlled Language
16%
Pharmacological Interventions
16%
Attention Memory
16%
Neuroscience
Cognitive Disorders
100%
Schizophrenia
100%
Cognitive Function
16%
Cholinergic
16%
Dopaminergic
16%
Motor Control
16%
Serotonergic
16%
Executive Function
16%